Sanofi Reports - Industry Research
Reports Featuring Sanofi
Over The Counter Drugs Market
The Over The Counter Drugs Market size is estimated at USD 137.39 billion in 2024, and is expected to reach USD 163.10 billion by 2029, growing at a CAGR of 3.49% during the forecast period (2024-2029).
Insomnia Treatment Market
The Insomnia Treatment Market size is estimated at USD 3.58 billion in 2024, and is expected to reach USD 4.60 billion by 2029, growing at a CAGR of 5.16% during the forecast period (2024-2029).
Middle East And Africa Glucagon-like Peptide-1 (GLP-1) Agonists Market
The Middle East And Africa Glucagon-like Peptide-1 Agonists Market size is estimated at USD 124.32 million in 2024, and is expected to reach USD 175.28 million by 2029, growing at a CAGR of 7.26% during the forecast period (2024-2029).
Middle East And Africa Human Insulin Market
The Middle East And Africa Human Insulin Market size is estimated at USD 1.62 billion in 2024, and is expected to reach USD 1.95 billion by 2029, growing at a CAGR of 3.78% during the forecast period (2024-2029).
Middle East and Africa Diabetes Drugs Market
The Middle East and Africa Diabetes Drugs Market size is estimated at USD 4.57 billion in 2023 and is expected to reach USD 6.10 billion by 2028, growing at a CAGR of 5.97% during the forecast period (2023-2028).
Global Pediatric Vaccines Market
The Global Pediatric Vaccines Market size is estimated at USD 20.29 billion in 2024, and is expected to reach USD 27.60 billion by 2029, growing at a CAGR of 6.34% during the forecast period (2024-2029).
Allergy Treatment Market
The Allergy Treatment Market size is estimated at USD 21.05 billion in 2024, and is expected to reach USD 31.07 billion by 2029, growing at a CAGR of 8.10% during the forecast period (2024-2029).
Paracetamol Market
The Paracetamol Market is expected to register a CAGR of 4.3% over the forecast period.
Generic Drugs Market
The Generic Drugs Market size is estimated at USD 413.60 billion in 2024, and is expected to reach USD 508.79 billion by 2029, growing at a CAGR of 4.23% during the forecast period (2024-2029).
Acute Myeloid Leukemia Market
The Acute Myeloid Leukemia Market size is estimated at USD 1.83 billion in 2024, and is expected to reach USD 2.97 billion by 2029, growing at a CAGR of 10.15% during the forecast period (2024-2029).
North America Human Insulin Drugs Market
The North America Human Insulin Drugs Market size is estimated at USD 11.58 billion in 2024, and is expected to reach USD 14.03 billion by 2029, growing at a CAGR of 3.91% during the forecast period (2024-2029).
Human Insulin Drugs Market
The Human Insulin Drugs Market size is estimated at USD 27.96 billion in 2024, and is expected to reach USD 33.81 billion by 2029, growing at a CAGR of 3.87% during the forecast period (2024-2029).
Asia-Pacific Cancer Vaccines Market
The Asia-Pacific Cancer Vaccines Market size is estimated at USD 2.34 billion in 2024, and is expected to reach USD 4.06 billion by 2029, growing at a CAGR of 11.55% during the forecast period (2024-2029).
Orthobiologics Market
The Orthobiologics Market size is estimated at USD 6.28 billion in 2024, and is expected to reach USD 9.14 billion by 2029, growing at a CAGR of 6.30% during the forecast period (2024-2029).
North America Biguanide Market
The North America Biguanide Market size is estimated at USD 1.36 billion in 2024, and is expected to reach USD 1.58 billion by 2029, growing at a CAGR of 2.59% during the forecast period (2024-2029).
Europe Insulin Delivery Devices Market
The Europe Insulin Delivery Devices Market size is estimated at USD 2.83 billion in 2024, and is expected to reach USD 3.12 billion by 2029, growing at a CAGR of 1.9% during the forecast period (2024-2029).
Insulin Pens Market
The Insulin Pens Market size is estimated at USD 33.31 billion in 2024, and is expected to reach USD 39.36 billion by 2029, growing at a CAGR of 3.40% during the forecast period (2024-2029).
Topical Analgesic Market
The topical analgesic market size is expected to grow from USD 4.58 billion in 2023 to USD 6.26 billion by 2028, registering a CAGR of 6.44% during the forecast period.
Human Insulin Drugs And Delivery Devices Market
The Human Insulin Drugs And Delivery Devices Market size is estimated at USD 67.45 billion in 2024, and is expected to reach USD 80.99 billion by 2029, growing at a CAGR of 3.73% during the forecast period (2024-2029).
Pharmaceutical Intermediates Market
The Pharmaceutical Intermediates Market size is estimated at USD 42.31 billion in 2024, and is expected to reach USD 60.52 billion by 2029, growing at a CAGR of 7.42% during the forecast period (2024-2029).
Influenza Vaccine Market
The Influenza Vaccine Market is expected to register a CAGR of 5.65% during the forecast period.
Pharmaceutical Manufacturing Market
The Pharmaceutical Manufacturing Market size is estimated at USD 465.16 billion in 2024, and is expected to reach USD 967.12 billion by 2029, growing at a CAGR of 12.14% during the forecast period (2024-2029).
Germany OTC Drug Market
The Germany OTC Drug Market size is estimated at USD 9.11 billion in 2024, and is expected to reach USD 11.19 billion by 2029, growing at a CAGR of 4.23% during the forecast period (2024-2029).
US Diabetes Care Drugs Market
The US Diabetes Care Drugs Market size is estimated at USD 32.59 billion in 2024, and is expected to reach USD 39.08 billion by 2029, growing at a CAGR of 3.70% during the forecast period (2024-2029).
Thailand Diabetes Care Drugs Market
The Thailand Diabetes Care Drugs Market size is estimated at USD 152.23 million in 2024, and is expected to reach USD 173.23 million by 2029, growing at a CAGR of 3.80% during the forecast period (2024-2029).
Philippines Diabetes Care Drugs Market
The Philippines Diabetes Care Drugs Market size is estimated at USD 264.24 million in 2024, and is expected to reach USD 319.95 million by 2029, growing at a CAGR of 3.9% during the forecast period (2024-2029).
South Korea Diabetes Drugs Market
The South Korea Diabetes Drugs Market size is estimated at USD 1 billion in 2024, and is expected to reach USD 1.22 billion by 2029, growing at a CAGR of 4.04% during the forecast period (2024-2029).
Iran Diabetes Care Drugs Market
The Iran Diabetes Care Drugs Market size is estimated at USD 331.92 million in 2024, and is expected to reach USD 401.90 million by 2029, growing at a CAGR of 3.9% during the forecast period (2024-2029).
Japan Diabetes Drugs Market
The Japan Diabetes Drugs Market size is estimated at USD 3.15 billion in 2024, and is expected to reach USD 4.03 billion by 2029, growing at a CAGR of 4.98% during the forecast period (2024-2029).
Asia-Pacific Insulin Pens Market
The Asia-Pacific Insulin Pens Market size is estimated at USD 17.46 billion in 2024, and is expected to reach USD 20.03 billion by 2029, growing at a CAGR of 2.70% during the forecast period (2024-2029).
United States Insulin Drugs And Delivery Devices Market
The United States Insulin Drugs And Delivery Devices Market size is estimated at USD 19.70 billion in 2024, and is expected to reach USD 22.5 billion by 2029, growing at a CAGR of 2.70% during the forecast period (2024-2029).
France Insulin Drugs And Delivery Devices Market
The France Insulin Drugs And Delivery Devices Market size is estimated at USD 736.48 million in 2024, and is expected to reach USD 789.49 million by 2029, growing at a CAGR of 1.40% during the forecast period (2024-2029).
UK Insulin Drugs And Delivery Devices Market
The UK Insulin Drugs And Delivery Devices Market size is estimated at USD 499.83 million in 2024, and is expected to reach USD 549.15 million by 2029, growing at a CAGR of 1.9% during the forecast period (2024-2029).
Canada Insulin Drugs And Delivery Devices Market
The Canada Insulin Drugs And Delivery Devices Market size is estimated at USD 1.68 billion in 2024, and is expected to reach USD 1.83 billion by 2029, growing at a CAGR of 1.7% during the forecast period (2024-2029).
Japan Insulin Drugs And Delivery Devices Market
The Japan Insulin Drugs And Delivery Devices Market size is estimated at USD 8.5 billion in 2024, and is expected to reach USD 9.57 billion by 2029, growing at a CAGR of 2.40% during the forecast period (2024-2029).
Japan Oral Anti-Diabetic Drug Market
The Japan Oral Anti-Diabetic Drug Market size is estimated at USD 2.42 billion in 2024, and is expected to reach USD 3.02 billion by 2029, growing at a CAGR of 4.60% during the forecast period (2024-2029).
Italy Oral Anti-Diabetic Drug Market
The Italy Oral Anti-Diabetic Drug Market size is estimated at USD 705.48 million in 2024, and is expected to reach USD 837.88 million by 2029, growing at a CAGR of 3.5% during the forecast period (2024-2029).
India Oral Anti-Diabetic Drug Market
The India Oral Anti-Diabetic Drug Market size is estimated at USD 1.7 billion in 2024, and is expected to reach USD 2.01 billion by 2029, growing at a CAGR of 3.5% during the forecast period (2024-2029).
New Zealand Oral Anti-Diabetic Drug Market
The New Zealand Oral Anti-Diabetic Drug Market size is estimated at USD 323 million in 2024, and is expected to reach USD 367.23 million by 2029, growing at a CAGR of 2.60% during the forecast period (2024-2029).
North America Oral Anti-Diabetic Drug Market
The North America Oral Anti-Diabetic Drug Market size is estimated at USD 18.76 billion in 2024, and is expected to reach USD 23.60 billion by 2029, growing at a CAGR of 4.70% during the forecast period (2024-2029).
Europe Oral Anti-Diabetic Drug Market
The Europe Oral Anti-Diabetic Drug Market size is estimated at USD 7.36 billion in 2024, and is expected to reach USD 8.70 billion by 2029, growing at a CAGR of 3.40% during the forecast period (2024-2029).
Asia-Pacific Oral Anti-Diabetic Drug Market
The Asia-Pacific Oral Anti-Diabetic Drug Market size is estimated at USD 25.37 billion in 2024, and is expected to reach USD 29.56 billion by 2029, growing at a CAGR of 3.10% during the forecast period (2024-2029).
Mexico Oral Anti-Diabetic Drug Market
Mexico's Oral Anti-Diabetic Drug Market is expected to register a CAGR of more than 3% during the forecast period, with revenue of USD 1.5 billion in the current year.
Brazil Oral Anti-Diabetic Drug Market
The Brazil Oral Anti-Diabetic Drug Market is expected to register a CAGR of more than 4% during the forecast period, with revenue of USD 861 million in the current year.
Malaysia Oral Anti-Diabetic Drug Market
The Malaysia Oral Anti-Diabetic Drug Market is expected to register a CAGR of over 3% during the forecast period.
India Insulin Drug And Delivery Device Market
India's Insulin Drug and Delivery Device Market is expected to register a CAGR of more than 1% and reach a value of about USD 2.4 billion over the forecast period.
Vietnam Insulin Drug And Delivery Device Market
Vietnam's Insulin Drug and Delivery Device Market is expected to register a CAGR of more than 2% and reach a value of about USD 483 million over the forecast period.
China Insulin Drugs And Delivery Devices Market
The China Insulin Drugs and Delivery Devices Market is expected to register a CAGR of 2.6% and reach a value of about USD 8.7 billion over the forecast period.
South Korea Oral Anti-Diabetic Drug Market
South Korea Oral Anti-Diabetic Drug Market is expected to register a CAGR of more than 3% during the forecast period and 506 million in revenue in the forecast period.
France Oral Anti-Diabetic Drug Market
France's Oral Anti-Diabetic Drug Market is expected to register a CAGR of more than 4% during the forecast period and revenue of USD 0.7 billion in the current year.
Vietnam Oral Anti-Diabetic Drug Market
The Vietnam Oral Anti-Diabetic Drug Market size is estimated at USD 156.21 million in 2024, and is expected to reach USD 195.32 million by 2029, growing at a CAGR of greater than 4% during the forecast period (2024-2029).
Indonesia Oral Anti-Diabetic Drug Market
The Indonesia Oral Anti-Diabetic Drug Market is expected to register a CAGR of more than 4% during the forecast period and USD 202 million in revenue in the current year.
Philippines Oral Anti-Diabetic Drug Market
The Philippines Oral Anti-Diabetic Drug Market size is estimated at USD 202.20 million in 2024, and is expected to reach USD 251.32 million by 2029, growing at a CAGR of greater than 4% during the forecast period (2024-2029).
Brazil Oral Anti-Diabetic Drug Market
The Brazil Oral Anti-Diabetic Drug Market is expected to register a CAGR of more than 3% during the forecast period, with revenue of USD 13 billion in the current year.
Thailand Oral Antidiabetic Drug Market
Thailand's Oral Anti-Diabetic Drug Market is expected to register a CAGR of more than 6% during the forecast period and 68 million in revenue in the current year.
South Africa Oral Antidiabetic Drug Market
The South Africa Oral Antidiabetic Drug Market size is estimated at USD 241.78 million in 2024, and is expected to reach USD 275.36 million by 2029, growing at a CAGR of greater than 2% during the forecast period (2024-2029).
South Korea Insulin Drugs And Delivery Devices Market
The South Korea Insulin Drugs And Delivery Devices Market size is estimated at USD 756.38 million in 2024, and is expected to reach USD 849.04 million by 2029, growing at a CAGR of 2.34% during the forecast period (2024-2029).
Latin America Insulin Pens Market
The Latin America Insulin Pens Market size is estimated at USD 0.4 billion in 2024, and is expected to reach USD 0.52 billion by 2029, growing at a CAGR of greater than 1.8% during the forecast period (2024-2029).
US Diabetes Drugs And Devices Market
The US Diabetes Drugs And Devices Market size is estimated at USD 60.12 billion in 2024, and is expected to reach USD 70.24 billion by 2029, growing at a CAGR of greater than 4% during the forecast period (2024-2029).
South Africa Diabetes Drugs and Devices Market
South Africa's diabetes care drugs and devices market size was estimated at USD 0.47 billion in the current year.
Russia Diabetes Drugs and Devices Market
Russian diabetes drugs and devices market is estimated at USD 2.2 billion in the current year.
India Diabetes Drugs and Devices Market
India's diabetes care drugs and devices market size is estimated at USD 3.8 billion in the current year.
Australia Diabetes Drugs and Devices Market
The Australian diabetes drugs and devices market size is estimated at USD 1.4 billion in the current year.
South Korea Diabetes Drugs and Devices Market
South Korea's diabetes drugs and devices market size is estimated at USD 1.4 billion in the current year.
Vietnam Diabetes Drugs and Devices Market
Vietnam's diabetes drugs and devices market size is estimated at USD 0.6 billion in the current year.
Spain Diabetes Drugs and Devices Market
Spain's diabetes drugs and devices market is estimated at USD 0.7 billion in the current year.
Germany Diabetes Drugs and Devices Market
Germany's diabetes drugs and devices market size is estimated at USD 6 billion in the current year.
Egypt Diabetes Drugs and Devices Market
Egypt's diabetes drugs and devices market size is estimated at USD 0.7 billion in the current year.
Mexico Diabetes Drugs and Devices Market
Mexico's diabetes drugs and devices market size is estimated at USD 2.4 billion in the current year.
China Diabetes Drugs And Devices Market
The China Diabetes Drugs And Devices Market size is estimated at USD 19.66 billion in 2024, and is expected to reach USD 22.77 billion by 2029, growing at a CAGR of greater than 3.5% during the forecast period (2024-2029).
Japan Diabetes Drugs And Devices Market
The Japan Diabetes Drugs And Devices Market size is estimated at USD 4.80 billion in 2024, and is expected to reach USD 6.40 billion by 2029, growing at a CAGR of greater than 3.20% during the forecast period (2024-2029).
Thailand Diabetes Drugs And Devices Market
The Thailand Diabetes Drugs And Devices Market size is estimated at USD 0.28 billion in 2024, and is expected to reach USD 0.35 billion by 2029, growing at a CAGR of greater than 5.02% during the forecast period (2024-2029).
Philippines Diabetes Drugs and Devices Market
Philippines diabetes drugs and devices market size is estimated at USD 0.3 billion in the current year.
Oman Diabetes Drugs And Devices Market
The Oman Diabetes Drugs And Devices Market size is estimated at USD 199.07 million in 2024, and is expected to reach USD 274.19 million by 2029, growing at a CAGR of greater than 5% during the forecast period (2024-2029).
Iran Diabetes Drugs and Devices Market
Iran's diabetes drugs and devices market size is estimated at USD 1 billion in the current year.
Injectable Anti-diabetic Drugs Market
The Injectable Anti-diabetic Drugs Market size is estimated at USD 38.79 billion in 2024, and is expected to reach USD 45.10 billion by 2029, growing at a CAGR of greater than 3% during the forecast period (2024-2029).
Expectorant Drugs Market
The Expectorant Drugs Market size is estimated at USD 100 million in 2024, and is expected to reach USD 120 million by 2029, growing at a CAGR of 4.5% during the forecast period (2024-2029).
South America Dietary Supplement Market
South America Dietary Supplement market is projected to grow at a CAGR of 7.7% during the forecast period (2020 - 2025).
Antidepressant Market
The antidepressant market is expected to register a CAGR of 3.5% over the forecast period.
Prostate Cancer Diagnostics and Therapy Market
The prostate cancer diagnostics and therapy market was expected to register a CAGR of nearly 13.7% during the forecast period.
Europe Clinical Trials Market
The European clinical trials market is expected to register a CAGR of 4.2% over the forecast period.
Spain Over-the-counter (OTC) Drugs Market
The Spain over-the-counter (OTC) drugs market registered a CAGR of nearly 5.4% over the forecast period, 2022-2027.
Europe Insulin Drugs Market
The Europe Insulin Drugs Market size is estimated at USD 5.95 billion in 2024, and is expected to reach USD 7.55 billion by 2029, growing at a CAGR of 4.89% during the forecast period (2024-2029).
_Drugs_Market_1.webp)
Asia-Pacific Over-the-counter (OTC) Drugs Market
The growth propelling factors of the Asia-Pacific over-the-counter (OTC) drugs market are product innovations, high penetration in emerging countries, like India and China, and the inclination of pharmaceutical companies toward OTC drugs over prescription drugs.
Diabetes Care Drugs Market
The Diabetes Care Drugs Market size is estimated at USD 87.53 billion in 2024, and is expected to reach USD 104.01 billion by 2029, growing at a CAGR of 3.51% during the forecast period (2024-2029).
Insulin Delivery Devices Market
The Insulin Delivery Devices Market size is estimated at USD 39.57 billion in 2024, and is expected to reach USD 47.17 billion by 2029, growing at a CAGR of 3.57% during the forecast period (2024-2029).
Osteoarthritis Treatment Market
The Osteoarthritis Treatment Market size is estimated at USD 7.33 billion in 2024, and is expected to reach USD 9.24 billion by 2029, growing at a CAGR of 4.74% during the forecast period (2024-2029).
Antacids Market
The Global Antacids Market size is expected to grow from USD 6,810.11 million in 2023 to USD 8,194.33 million by 2028, registering a CAGR of 3.7% during the forecast period (2023-2028).
Global Rabies Vaccine Market
The rabies vaccine market is expected to register a CAGR of 5.1% over the forecast period.
Europe Diabetes Drugs Market
The Europe Diabetes Drugs Market size is estimated at USD 16.43 billion in 2024, and is expected to reach USD 20.23 billion by 2029, growing at a CAGR of 4.25% during the forecast period (2024-2029).
Oral Anti-Diabetic Drugs Market
The Oral Anti-Diabetic Drugs Market size is estimated at USD 46.82 billion in 2024, and is expected to reach USD 57.44 billion by 2029, growing at a CAGR of 4.17% during the forecast period (2024-2029).
Basal Insulin Market
The Basal Insulin Market size is estimated at USD 273.68 million in 2024, and is expected to reach USD 344.33 million by 2029, growing at a CAGR of 4.70% during the forecast period (2024-2029).
Ear Infection Treatment Market
The Ear Infection Treatment Market size is estimated at USD 12.23 billion in 2024, and is expected to reach USD 15.09 billion by 2029, growing at a CAGR of 4.29% during the forecast period (2024-2029).
Global Bronchitis Treatment Market
The bronchitis treatment market is expected to grow at a CAGR of 3.6% over the forecast period (2022-2027).
Global Constipation Treatment Market
The constipation treatment market is expected to register a CAGR of nearly 6.9% during the forecast period of 2022-2027.
Dysmenorrhea Treatment Market
The dysmenorrhea treatment market is expected to register a CAGR of 8.1% during the forecast period.
Tetanus Toxoid Vaccine Market
The tetanus toxoid vaccine market is expected to register a CAGR of 4.8% during the forecast period.
Global Viscosupplementation Market
The viscosupplementation market is projected to grow with a CAGR of 5.8% during the forecast period (2022 - 2027).
Intravenous Iron Drugs Market
The intravenous iron drugs market is expected to grow at a significant CAGR of 8.35% during the forecast period.
New Zealand Insulin Drugs and Devices Market
The New Zealand Insulin Drugs and Devices Market size is estimated at USD 523.18 million in 2024, and is expected to reach USD 552.60 million by 2029, growing at a CAGR of 1.10% during the forecast period (2024-2029).
New Zealand Diabetes Drugs Market
The New Zealand Diabetes Drugs Market size is estimated at USD 717.24 million in 2024, and is expected to reach USD 872.63 million by 2029, growing at a CAGR of 4% during the forecast period (2024-2029).
New Zealand Diabetes Devices Market
The New Zealand Diabetes Devices Market size is estimated at USD 435.36 million in 2024, and is expected to reach USD 512.09 million by 2029, growing at a CAGR of 3.30% during the forecast period (2024-2029).
Omega-3 Products Market
The Omega-3 Products Market size is estimated at USD 47.77 billion in 2024, and is expected to reach USD 68.86 billion by 2029, growing at a CAGR of 7.59% during the forecast period (2024-2029).
India Drug Delivery Devices Market
The India Drug Delivery Devices Market is poised at a CAGR of nearly 5.5% during the forecast period (2022-2027).
Brazil Drug Delivery Devices Market
The Brazil drug delivery devices market is expected to register a CAGR of 4.5% over the forecast period.
North America Over the Counter Drugs Market
The North America Over the Counter (OTC) Drugs Market is anticipated to grow with a CAGR of 2.7%, during the forecast period.
Global Leukemia Therapeutics Market
The Leukemia Therapeutics Market is expected to register a CAGR of 5.5% over the forecast period.
Healthcare Nanotechnology (Nanomedicine) Market
The healthcare nanotechnology (nanomedicine) market is expected to register a CAGR of nearly 11.9% during the forecast period.
Global Cytokine Market
The cytokine market is expected to register a CAGR of 6.2% during the forecast period (2022-2027).
North America Diabetes Drugs Market
The North America Diabetes Drugs Market size is estimated at USD 35.82 billion in 2024, and is expected to reach USD 42.36 billion by 2029, growing at a CAGR of 3.58% during the forecast period (2024-2029).
Spain Diabetes Devices Market
The Spain Diabetes Devices Market size is estimated at USD 0.71 billion in 2024, and is expected to reach USD 1.02 billion by 2029, growing at a CAGR of 7.41% during the forecast period (2024-2029).
Asia - Pacific Human Insulin Market
The Asia - Pacific Human Insulin Market size is estimated at USD 7.29 billion in 2023, and is expected to reach USD 8.27 billion by 2028, growing at a CAGR of 2.54% during the forecast period (2023-2028).
Iron Deficiency Anemia Therapy Market
The Iron Deficiency Anemia Therapy Market size is estimated at USD 3.69 billion in 2024, and is expected to reach USD 4.84 billion by 2029, growing at a CAGR of 5.60% during the forecast period (2024-2029).
Global Recombinant DNA (rDNA) Technology Market
The recombinant DNA (rDNA) technology market is projected to register a CAGR of 6.8% during the forecast period (2022-2027).
Asia-Pacific Glucagon-like Peptide-1 (GLP-1) Agonists Market
The Asia-Pacific Glucagon-like Peptide-1 Agonists Market size is estimated at USD 0.9 billion in 2024, and is expected to reach USD 1.17 billion by 2029, growing at a CAGR of 5.38% during the forecast period (2024-2029).
Europe Glucagon-Like Peptide-1 (GLP-1) Agonists Market
The Europe Glucagon-Like Peptide-1 Agonists Market size is estimated at USD 3.94 billion in 2024, and is expected to reach USD 5.25 billion by 2029, growing at a CAGR of 5.90% during the forecast period (2024-2029).
North America Glucagon-like Peptide-1 Agonists Market
The North America Glucagon-like Peptide-1 Agonists Market size is estimated at USD 6.94 billion in 2024, and is expected to decline to USD 6.68 billion by 2029.
Glucagon-like Peptide-1 (GLP-1) Agonists Market
The Glucagon-like Peptide-1 Agonists Market size is estimated at USD 11.99 billion in 2024, and is expected to reach USD 12.63 billion by 2029, growing at a CAGR of 1.12% during the forecast period (2024-2029).
Asia-Pacific Diabetes Care Drugs Market
The Asia-Pacific Diabetes Care Drugs Market size is estimated at USD 24.99 billion in 2024, and is expected to reach USD 28.70 billion by 2029, growing at a CAGR of 2.81% during the forecast period (2024-2029).
Latin America Diabetes Care Drugs Market
The Latin America Diabetes Care Drugs Market size is estimated at USD 4.71 billion in 2024, and is expected to reach USD 5.58 billion by 2029, growing at a CAGR of 3.48% during the forecast period (2024-2029).
Sulfonylureas Market
The Sulfonylureas Market size is estimated at USD 9.98 billion in 2024, and is expected to reach USD 11.32 billion by 2029, growing at a CAGR of 3.12% during the forecast period (2024-2029).
Non-opioid Pain Patch Market
The non-opioid pain patch market is expected to register a CAGR of 3.0% during the forecast period.
Thrombosis Drugs Market
The thrombosis drugs market is expected to register a CAGR of about 9.0% over the forecast period.
MEA Insulin Pens Market
The MEA Insulin Pens Market size is estimated at USD 1.02 billion in 2024, and is expected to reach USD 1.13 billion by 2029, growing at a CAGR of 2.19% during the forecast period (2024-2029).
Europe Insulin Pens Market
The Europe Insulin Pens Market size is estimated at USD 2.13 billion in 2023 and is expected to reach USD 2.29 billion by 2028, growing at a CAGR of 1.45% during the forecast period (2023-2028).
Mergers And Acquisitions In The Diabetes Market
The Mergers And Acquisitions In The Diabetes Market size is estimated at USD 85.73 billion in 2024, and is expected to reach USD 102.76 billion by 2029, growing at a CAGR of 3.69% during the forecast period (2024-2029).
Meningococcal Vaccines Market
The meningococcal vaccines market is expected to register a CAGR of around 9.5% over the forecast period.
Canada Diabetes Care Drugs And Devices Market
The Canada Diabetes Care Drugs And Devices Market size is estimated at USD 5.40 billion in 2024, and is expected to reach USD 7.04 billion by 2029, growing at a CAGR of 4.75% during the forecast period (2024-2029).
Global Artemisinin Combination Therapy Market
Over the next few years, the market for artemisinin combination therapy is expected to grow at a CAGR of 8.31%.
Multiple Sclerosis Therapeutics Market
The Multiple Sclerosis Therapeutics Market size is estimated at USD 29.65 billion in 2024, and is expected to reach USD 35.16 billion by 2029, growing at a CAGR of 3.46% during the forecast period (2024-2029).
Liver Diseases Therapeutics Market
During the forecast period, the market for medicines to treat liver disease is expected to register a CAGR of about 8.5%.
Sarcopenia Treatment Market
The Sarcopenia Treatment Market size is estimated at USD 3.07 billion in 2024, and is expected to reach USD 4.02 billion by 2029, growing at a CAGR of 4.48% during the forecast period (2024-2029).
Global Rare Hemophilia Factors Market
The rare hemophilia factors market is expected to record a CAGR of 4.3% over the forecast period (2022-2027).
Global Joint Pain Injections Market
Joint Pain Injections Market is expected to register a growth at a CAGR of 6% over the forecast period.
.
Global Hypertrophic Cardiomyopathy Therapeutics Market
The Hypertrophic Cardiomyopathy Therapeutics Market is expected to grow at a CAGR of 1.8% over the forecast period (2022-2027).
Nasal Polyps Treatment Market
The Nasal Polyps Treatment Market is anticipated to witness a CAGR of nearly 6.2% during the forecast period.
Global Hereditary Angioedema Therapeutics Market
The hereditary angioedema therapeutics market is expected to register a CAGR of 8.5% during the forecast period.
Lysosomal Storage Disease Treatment Market
The lysosomal storage disease treatment market is expected to register a CAGR of 8.2% during the forecast period.
Global Hyperlipidemia Drugs Market
The hyperlipidemia drugs market is expected to register a CAGR of 2.3% during the forecast period.
Iceland Pharmaceutical Market
The Iceland Pharmaceutical market studied was anticipated to show a low growth with a CAGR of 2.8%, during the forecast period (2022-2027).
Pompe Disease Market
The Pompe disease market is expected to register a CAGR of 4.5% over the forecast period.
Anemia Treatment Market
Over the next few years, the anemia treatment market is expected to register a CAGR of 7.3%.
Europe Insulin Drugs And Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market
The Europe Insulin Drugs And Glucagon-Like Peptide 1 Receptor Agonist Market size is estimated at USD 9.62 billion in 2024, and is expected to reach USD 12.05 billion by 2029, growing at a CAGR of 4.61% during the forecast period (2024-2029).
Global Diagnostics Enzyme
The diagnostics enzyme market is expected to register a CAGR of 6.2% during the forecast period of 2021-2026.
Penicillin Drug Market
The Penicillin Drug Market size is estimated at USD 10.71 billion in 2024, and is expected to reach USD 12.55 billion by 2029, growing at a CAGR of 3.21% during the forecast period (2024-2029).
High Potency APIs /HPAPI Market
The High Potency APIs /HPAPI Market size is estimated at USD 26.85 billion in 2024, and is expected to reach USD 41.83 billion by 2029, growing at a CAGR of 9.27% during the forecast period (2024-2029).
Global Fibrate Drugs Market
The fibrate drugs market is projected to register a CAGR of 5.2% during the forecast period.
Egypt Diabetes Drugs Market
The Egypt Diabetes Drugs Market size is estimated at USD 414.66 million in 2024, and is expected to reach USD 480.70 million by 2029, growing at a CAGR of 3% during the forecast period (2024-2029).
Saudi Arabia Diabetes Drugs Market
The Saudi Arabia Diabetes Drugs Market size is estimated at USD 1.87 billion in 2024, and is expected to reach USD 2.89 billion by 2029, growing at a CAGR of 9% during the forecast period (2024-2029).
Mexico Diabetes Drugs Market
The Mexico Diabetes Drugs Market size is estimated at USD 2.04 billion in 2024, and is expected to reach USD 2.39 billion by 2029, growing at a CAGR of 3.30% during the forecast period (2024-2029).
Vietnam Diabetes Care Drugs Market
The Vietnam Diabetes Care Drugs Market size is estimated at USD 208.45 million in 2024, and is expected to reach USD 249.97 million by 2029, growing at a CAGR of 3.70% during the forecast period (2024-2029).
India Diabetes Care Drugs Market
The India Diabetes Care Drugs Market size is estimated at USD 1.7 billion in 2024, and is expected to reach USD 2.01 billion by 2029, growing at a CAGR of 3.5% during the forecast period (2024-2029).
Russia Diabetes Drugs Market
The Russia Diabetes Drugs Market size is estimated at USD 1.04 billion in 2024, and is expected to reach USD 1.31 billion by 2029, growing at a CAGR of 4.5% during the forecast period (2024-2029).
Europe Omega-3 Products Market
The European omega-3 products market is projected to reach a CAGR of 7.00% over the next five years.
Human Recombinant Insulin Market
The Human Recombinant Insulin Market size is estimated at USD 28.47 billion in 2024, and is expected to reach USD 32.20 billion by 2029, growing at a CAGR of greater than 2.9% during the forecast period (2024-2029).
Biguanides Market
The Biguanides Market size is estimated at USD 5.20 billion in 2024, and is expected to reach USD 5.76 billion by 2029, growing at a CAGR of 2.07% during the forecast period (2024-2029).
Combination Anti-Diabetes Drugs Market
The Combination Anti-Diabetes Drugs Market size is estimated at USD 1.09 billion in 2024, and is expected to reach USD 1.85 billion by 2029, growing at a CAGR of 10.87% during the forecast period (2024-2029).
North America Insulin Delivery Devices Market
The North America Insulin Delivery Devices Market size is estimated at USD 14.59 million in 2024, and is expected to reach USD 18.91 million by 2029, growing at a CAGR of 5.06% during the forecast period (2024-2029).
North America Insulin Pens Market
The North America Insulin Pens Market size is estimated at USD 11.99 billion in 2024, and is expected to reach USD 14.87 billion by 2029, growing at a CAGR of 4.87% during the forecast period (2024-2029).
Global Cholera Vaccines Market
The cholera vaccines market is poised to grow at a CAGR of 9.8% over the forecast period.
Australia And New Zealand Diabetes Devices Market
The Australia And New Zealand Diabetes Devices Market size is estimated at USD 1.14 billion in 2024, and is expected to reach USD 1.30 billion by 2029, growing at a CAGR of 2.70% during the forecast period (2024-2029).
Psoriatic Arthritis Therapeutics Market
The psoriatic arthritis therapeutic market is expected to register a CAGR of 6.65% over the forecast period.
Hyperkalemia Treatment Market
The hyperkalemia treatment market is poised to register a CAGR of 16.79% over the forecast period.
Global Hematologic Malignancies Treatment Market
The Global Hematologic Malignancies Treatment Market size is estimated at USD 67.23 billion in 2024, and is expected to reach USD 97.73 billion by 2029, growing at a CAGR of 7.77% during the forecast period (2024-2029).
Global Immunosuppressant Drugs Market
The immunosuppressant drugs market is expected to register a CAGR of 4.6% during the forecast period.
Influenza Medications Market
Influenza has been recognised as a crucial cause of morbidity and mortality in the human population, which is leading to the development of novel drugs that are intended for reducing consequent health and economic impacts.
Hemoglobinopathies Treatment Market
The global hemoglobinopathies treatment market was studied and projected to grow with a CAGR of nearly 7% over the forecast period.
Blood Disorder Therapeutics Market
The Blood Disorder Therapeutics Market is expected to register a CAGR of 6.2% during the forecast period.
Meperidine Drugs Market
The global meperidine drugs market size is expected to grow at a CAGR of 4.1% over the forecast period.
Thyroid Cancer Therapeutics Market
The thyroid cancer therapeutics market is expected to register a CAGR of 12.4% during the forecast period.
Castrate Resistant Prostate Cancer Therapeutics Market
The Castrate Resistant Prostate Cancer Therapeutics Market is expected to register a CAGR of 6.5% during the forecast period.
Short-acting Insulin Market
The Short-acting Insulin Market size is estimated at USD 7.23 billion in 2024, and is expected to reach USD 8.58 billion by 2029, growing at a CAGR of 3.46% during the forecast period (2024-2029).
Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market
The market for non-steroidal anti-inflammatory drugs (NSAIDs) is expected to register a CAGR of 5.2% over the forecast period.
.
Graft Versus Host Disease Treatment Market
The Graft Versus Host disease treatment market is projected to register a CAGR of 8.4% during the forecast period.
Multiple Myeloma Market
The multiple myeloma market is expected to witness a CAGR of 6% over the forecast period.
Global Ethical Pharmaceuticals Market
The Ethical Pharmaceuticals Market is expected to register a CAGR of 10.5% during the forecast period (2022-2027).
Insulin Glargine Market
The Insulin Glargine Market size is estimated at USD 1.54 billion in 2024, and is expected to reach USD 2.09 billion by 2029, growing at a CAGR of 6.28% during the forecast period (2024-2029).
Oman Diabetes Drugs Market
The Oman Diabetes Drugs Market size is estimated at USD 212.26 million in 2024, and is expected to reach USD 292.31 million by 2029, growing at a CAGR of 6.61% during the forecast period (2024-2029).
South Africa Diabetes Drugs Market
The South Africa Diabetes Drugs Market size is estimated at USD 340.72 million in 2024, and is expected to reach USD 384.74 million by 2029, growing at a CAGR of 2.46% during the forecast period (2024-2029).
Indonesia Diabetes Care Drugs Market
The Indonesia Diabetes Care Drugs Market size is estimated at USD 301.55 million in 2024, and is expected to reach USD 370.43 million by 2029, growing at a CAGR of 4.20% during the forecast period (2024-2029).
Malaysia Diabetes Care Drugs Market
The Malaysia Diabetes Care Drugs Market size is estimated at USD 389.13 million in 2024, and is expected to reach USD 423.21 million by 2029, growing at a CAGR of 3.10% during the forecast period (2024-2029).
China Diabetes Care Drugs Market
The China Diabetes Care Drugs Market size is estimated at USD 12.34 billion in 2024, and is expected to reach USD 14.10 billion by 2029, growing at a CAGR of 2.70% during the forecast period (2024-2029).
Latin America Oral Anti-Diabetic Drug Market
The Latin America Oral Anti-Diabetic Drug Market size is estimated at USD 3.25 billion in 2024, and is expected to reach USD 3.86 billion by 2029, growing at a CAGR of 3.5% during the forecast period (2024-2029).
Skin Cancer Therapeutics Market
The Skin Cancer Therapeutics Market is poised to grow at a CAGR of 10.1% over the forecast period.
Europe Novel Drug Delivery System (NDDS) Market
European novel drug delivery system market primarily driven by technological advancements promoting the development of NDDS and the rising need for controlled release of drugs.
Europe Biguanide Market
The Europe Biguanide Market size is estimated at USD 1.25 billion in 2024, and is expected to reach USD 1.33 billion by 2029, growing at a CAGR of 1.27% during the forecast period (2024-2029).
Middle East and Africa Biguanide Market
The Middle East and Africa Biguanide Market size is estimated at USD 311.96 million in 2024, and is expected to reach USD 370.86 million by 2029, growing at a CAGR of 3.52% during the forecast period (2024-2029).
Asia-Pacific Insulin Delivery Devices Market
The Asia-Pacific Insulin Delivery Devices Market size is estimated at USD 18.88 billion in 2024, and is expected to reach USD 21.55 billion by 2029, growing at a CAGR of greater than 2.68% during the forecast period (2024-2029).
Middle East and Africa Insulin Delivery Devices Market
The Middle East and Africa Insulin Delivery Devices Market size is estimated at USD 1.96 billion in 2024, and is expected to reach USD 2.27 billion by 2029, growing at a CAGR of 2.99% during the forecast period (2024-2029).
Organ Transplant Immunosuppressant Drugs Market
The organ transplant immunosuppressant drugs market is expected to register a CAGR of 3.5% during the forecast period.
H1N1 Vaccines Market
The H1N1 Vaccines Market is expected to register a CAGR of 5.2% during the forecast period.
PAP and Paracetamol Market
The PAP and Paracetamol Market is expected to register a CAGR of 4.3% during the forecast period.
Montelukast Sodium Market
The Montelukast Sodium Market size is estimated at USD 4.08 billion in 2024, and is expected to reach USD 7.38 billion by 2029, growing at a CAGR of 12.60% during the forecast period (2024-2029).
Cardiac Arrhythmia Therapeutics Market
The Cardiac Arrhythmia Therapeutics Market is expected to register a CAGR of 4.3% during the forecast period.
.webp)
Uropathy Treatment Market
The Uropathy Treatment Market is expected to register a CAGR of 4.2% during the forecast period.
Hyaluronic Acid Raw Material Market
The hyaluronic acid raw material market is expected to witness a CAGR of 6.5% during the forecast period.
Hydroxychloroquine Drugs Market
The global hydroxychloroquine drugs market studied was anticipated to register a CAGR of nearly 16.8% during the forecast period.
Pruritus Therapeutics Market
The pruritus therapeutics market is expected to grow at a CAGR of 3.5% during the forecast period.
Global Neurology Clinical Trials Market
The neurology clinical trials market is expected to register a CAGR of 4.35% during the forecast period (2022-2027).
Microneedle Flu Vaccine Market
The Microneedle Flu Vaccine Market size is estimated at USD 1.52 billion in 2024, and is expected to reach USD 2.13 billion by 2029, growing at a CAGR of 6.95% during the forecast period (2024-2029).
Global Acute Otitis Media Treatment Market
The acute otitis media treatment market is expected to register a CAGR of 5.5% during the forecast period, 2022-2027.
Germany Diabetes Drugs Market
The Germany Diabetes Drugs Market size is estimated at USD 4.06 billion in 2024, and is expected to reach USD 4.81 billion by 2029, growing at a CAGR of 3.47% during the forecast period (2024-2029).
Italy Diabetes Drugs Market
The Italy Diabetes Drugs Market size is estimated at USD 1.12 billion in 2024, and is expected to reach USD 1.31 billion by 2029, growing at a CAGR of 3% during the forecast period (2024-2029).
United Kingdom (UK) Diabetes Drugs Market
The United Kingdom Diabetes Drugs Market size is estimated at USD 1.06 billion in 2024, and is expected to reach USD 1.24 billion by 2029, growing at a CAGR of 3.05% during the forecast period (2024-2029).
France Diabetes Drugs Market
The France Diabetes Drugs Market size is estimated at USD 1.42 billion in 2024, and is expected to reach USD 1.67 billion by 2029, growing at a CAGR of 3.22% during the forecast period (2024-2029).
Spain Diabetes Care Drugs Market
The Spain Diabetes Care Drugs Market size is estimated at USD 1.21 billion in 2024, and is expected to reach USD 1.52 billion by 2029, growing at a CAGR of 4.5% during the forecast period (2024-2029).
Brazil Diabetes Drugs Market
The Brazil Diabetes Drugs Market size is estimated at USD 1.66 billion in 2024, and is expected to reach USD 2.02 billion by 2029, growing at a CAGR of 4.10% during the forecast period (2024-2029).
Australia Diabetes Care Drugs Market
The Australia Diabetes Care Drugs Market size is estimated at USD 815.19 million in 2024, and is expected to reach USD 972.88 million by 2029, growing at a CAGR of 3.60% during the forecast period (2024-2029).
North America Sulfonylureas Market
The North America Sulfonylureas Market size is estimated at USD 3.11 billion in 2024, and is expected to reach USD 3.41 billion by 2029, growing at a CAGR of 1.9% during the forecast period (2024-2029).
Latin America Glucagon-like Peptide-1 (GLP-1) Agonists Market
The Latin America Glucagon-like Peptide-1 Agonists Market size is estimated at USD 203.89 million in 2024, and is expected to reach USD 266.48 million by 2029, growing at a CAGR of 5.5% during the forecast period (2024-2029).
Fabry Disease Treatment Market
The Fabry disease treatment market is expected to register a CAGR of 6.8% over the forecast period.
APAC Biguanide Market
The APAC Biguanide Market size is estimated at USD 1.97 billion in 2024, and is expected to reach USD 2.17 billion by 2029, growing at a CAGR of 2% during the forecast period (2024-2029).
Latin America Biguanide Market
The Latin America Biguanide Market size is estimated at USD 386.66 million in 2024, and is expected to reach USD 443.91 million by 2029, growing at a CAGR of 2.80% during the forecast period (2024-2029).
Latin America Human Insulin Drugs Market
The Latin America Human Insulin Drugs Market size is estimated at USD 1.51 billion in 2024, and is expected to reach USD 1.75 billion by 2029, growing at a CAGR of 3.10% during the forecast period (2024-2029).
Germany Insulin Drugs And Delivery Devices Market
The Germany Insulin Drugs And Delivery Devices Market size is estimated at USD 1.10 billion in 2024, and is expected to reach USD 1.13 billion by 2029, growing at a CAGR of 0.5% during the forecast period (2024-2029).
Spain Insulin Drugs And Delivery Devices Market
The Spain Insulin Drugs and Delivery Devices Market size is estimated at USD 0.35 billion in current year, and is expected to reach USD 0.38 million by forecast year, growing at a CAGR of 1.80% during the forecast period.
Italy Insulin Drugs and Delivery Devices Market
The Italy Insulin Drugs and Delivery Devices Market size is estimated at USD 531.86 million in 2024, and is expected to reach USD 572.96 million by 2029, growing at a CAGR of 1.5% during the forecast period (2024-2029).
Russia Insulin Drugs and Delivery Devices Market
The Russia Insulin Drugs and Delivery Devices Market size is estimated at USD 1.10 billion in 2024, and is expected to reach USD 1.14 billion by 2029, growing at a CAGR of 0.58% during the forecast period (2024-2029).
Mexico Insulin Drugs And Delivery Devices Market
The Mexico Insulin Drugs And Delivery Devices Market size is estimated at USD 546.96 million in 2024, and is expected to reach USD 572.01 million by 2029, growing at a CAGR of 0.9% during the forecast period (2024-2029).
Brazil Insulin Drugs & Delivery Devices Market
The Brazil Insulin Drugs & Delivery Devices Market size is estimated at USD 937.42 million in 2024, and is expected to reach USD 990.12 million by 2029, growing at a CAGR of 1.10% during the forecast period (2024-2029).
Latin America Insulin Delivery Devices Market
The Latin America Insulin Delivery Devices Market size is estimated at USD 7.14 million in 2024, and is expected to reach USD 8.16 million by 2029, growing at a CAGR of greater than 2% during the forecast period (2024-2029).
Head and Neck Cancer Therapeutics Market
The Head and Neck Cancer Therapeutics Market is expected to register a CAGR of 9% over the forecast period.
Other Reports Covering Sanofi
Biotechnology
- Biopharmaceuticals Market
- Blood Preparation Market
- Clinical Trials Market
- Clinical Trials Support Services Market
- Drug Discovery Market
- Europe Clinical Trials Market
- Global Cytokine Market
- Global Neurology Clinical Trials Market
- Global Oncology Clinical Trials Market
- Global Recombinant DNA (rDNA) Technology Market
- Global Viral Vector Manufacturing Market
- Healthcare Nanotechnology (Nanomedicine) Market
- Human Recombinant Insulin Market
- Hyaluronic Acid Raw Material Market
- Pharmaceutical Manufacturing Market
- Recombinant Protein Market
Device Drug Combination
- Asia Pacific Liver Cancer Market
- Asia-Pacific Bladder Cancer Therapeutics and Diagnostics Market
- Asia-Pacific Diabetes Care Devices Market
- Asia-Pacific Insulin Pens Market
- Australia And New Zealand Diabetes Devices Market
- Australia Diabetes Care Devices Market
- Australia Diabetes Drugs and Devices Market
- Australia Drug Delivery Devices Market
- Australia Insulin Delivery Devices Market
- Brazil Diabetes Care Devices Market
- Brazil Drug Delivery Devices Market
- Brazil Insulin Drugs & Delivery Devices Market
- Canada Diabetes Care Devices Market
- Canada Diabetes Care Drugs And Devices Market
- Canada Insulin Delivery Devices Market
- Canada Insulin Drugs And Delivery Devices Market
- China Diabetes Devices Market
- China Diabetes Drugs And Devices Market
- China Insulin Drugs And Delivery Devices Market
- Colorectal Cancer Diagnostics and Therapeutics Market
- Egypt Diabetes Care Devices Market
- Egypt Diabetes Drugs and Devices Market
- Epinephrine Autoinjector Market
- Europe Bladder Cancer Therapeutics and Diagnostics Market
- Europe Diabetes Care Devices Market
- Europe Insulin Delivery Devices Market
- Europe Insulin Pens Market
- France Drug Delivery Devices Market
- France Insulin Drugs And Delivery Devices Market
- Germany Diabetes Drugs and Devices Market
- Germany Insulin Drugs And Delivery Devices Market
- Global Skin Cancer Diagnostics and Therapeutics Market
- Graft Versus Host Disease Treatment Market
- Graft Versus Host Disease Treatment Market
- Human Insulin Drugs And Delivery Devices Market
- India Diabetes Devices Market
- India Diabetes Drugs and Devices Market
- India Drug Delivery Devices Market
- Indonesia Diabetes Care Devices Market
- Indonesia Oral Anti-Diabetic Drug Market
- Insulin Delivery Devices Market
- Insulin Pens Market
- Iran Diabetes Care Devices Market
- Iran Diabetes Drugs and Devices Market
- Italy Diabetes Care Devices Market
- Italy Insulin Drugs and Delivery Devices Market
- Japan Diabetes Care Devices Market
- Japan Diabetes Drugs And Devices Market
- Japan Insulin Drugs And Delivery Devices Market
- Latin America Diabetes Care Devices Market
- Latin America Insulin Delivery Devices Market
- Malaysia Diabetes Care Devices Market
- MEA Bladder Cancer Therapeutics & Diagnostics Market
- MEA Insulin Pens Market
- MEA Uterine Cancer Therapeutics & Diagnostics Market
- Mexico Diabetes Care Devices Market
- Mexico Diabetes Drugs and Devices Market
- Mexico Insulin Drugs And Delivery Devices Market
- Middle East and Africa Diabetes Care Devices Market
- Middle East and Africa Insulin Delivery Devices Market
- New Zealand Diabetes Devices Market
- New Zealand Insulin Drugs and Devices Market
- Non-opioid Pain Patch Market
- North America Bladder Cancer Therapeutics and Diagnostics Market
- North America Diabetes Care Devices Market
- North America Insulin Delivery Devices Market
- North America Insulin Pens Market
- Oman Diabetes Care Devices Market
- Oman Diabetes Drugs And Devices Market
- Pediatric Healthcare Market
- Philippines Diabetes Care Devices Market
- Philippines Diabetes Drugs and Devices Market
- Philippines Oral Anti-Diabetic Drug Market
- Prostate Cancer Diagnostics and Therapy Market
- Prostate Health Market
- Russia Diabetes Care Devices Market
- Russia Diabetes Drugs and Devices Market
- Russia Insulin Drugs and Delivery Devices Market
- Saudi Arabia Diabetes Care Devices Market
- Skin Cancer Therapeutics Market
- South Africa Diabetes Drugs and Devices Market
- South Africa Oral Antidiabetic Drug Market
- South America Bladder Cancer Therapeutics and Diagnostics Market
- South Korea Diabetes Care Devices Market
- South Korea Diabetes Drugs and Devices Market
- South Korea Insulin Drugs And Delivery Devices Market
- Spain Diabetes Devices Market
- Spain Diabetes Drugs and Devices Market
- Spain Insulin Drugs And Delivery Devices Market
- Thailand Diabetes Care Devices Market
- Thailand Diabetes Drugs And Devices Market
- Thailand Oral Antidiabetic Drug Market
- Type 2 Diabetes Drugs And Devices Market
- UK Insulin Drugs And Delivery Devices Market
- United Kingdom (UK) Diabetes Care Devices Market
- United States Diabetes Devices Market
- United States Drug Delivery Devices Market
- United States Insulin Drugs And Delivery Devices Market
- US Diabetes Drugs And Devices Market
- Uterine Cancer Therapeutics & Diagnostics Market
- Vietnam Diabetes Care Devices Market
- Vietnam Diabetes Drugs and Devices Market
- Vietnam Insulin Drug And Delivery Device Market
- Vietnam Oral Anti-Diabetic Drug Market
Medical Devices
- Asia-Pacific Insulin Delivery Devices Market
- Brazil Oral Anti-Diabetic Drug Market
- Europe Novel Drug Delivery System (NDDS) Market
- France Diabetes Devices Market
- France Oral Anti-Diabetic Drug Market
- Germany Diabetes Care Devices Market
- Global Acute Otitis Media Treatment Market
- Global Diagnostics Enzyme
- India Insulin Drug And Delivery Device Market
- India Insulin Infusion Pump Market
- North America Novel Drug Delivery Systems (NDDS) Market
- Short-acting Insulin Market
- South Africa Diabetes Care Devices Market
- South Korea Oral Anti-Diabetic Drug Market
- Surgical Sealant and Adhesives Market
Pharmaceuticals
- Immunotherapy Drugs Market
- Preventive Vaccines Market
- Acute Lymphoblastic Leukemia Therapeutics Market
- Acute Myeloid Leukemia Market
- Allergy Treatment Market
- Anal Cancer Market
- Anemia Treatment Market
- Antacids Market
- Anti-infective Drugs Market
- Anti-Viral Therapeutics Market
- Antidepressant Market
- Antihistamine Market
- Antithrombotic Drugs Market
- APAC Biguanide Market
- Asia - Pacific Human Insulin Market
- Asia-Pacific Cancer Vaccines Market
- Asia-Pacific Diabetes Care Drugs Market
- Asia-Pacific Glucagon-like Peptide-1 (GLP-1) Agonists Market
- Asia-Pacific Oral Anti-Diabetic Drug Market
- Asia-Pacific Over-the-counter (OTC) Drugs Market
- Asthma and COPD Drugs Market
- Atopic Dermatitis Market
- Australia Diabetes Care Drugs Market
- Australia Pharmaceuticals Market
- Basal Cell Carcinoma Treatment Market
- Basal Insulin Market
- Belgium Pharmaceutical Market
- Benign Prostatic Hyperplasia Market
- Biguanides Market
- Biobetters Market
- Biologics Market
- Blood Disorder Therapeutics Market
- Brazil Diabetes Drugs Market
- Brazil Oral Anti-Diabetic Drug Market
- Calcium Channel Blocker Market
- Cancer Vaccines Market
- Cardiac Arrhythmia Therapeutics Market
- Cardiovascular Drugs Market
- Castrate Resistant Prostate Cancer Therapeutics Market
- China Diabetes Care Drugs Market
- Chronic Lymphocytic Leukemia Market
- Chronic Myelogenous Leukemia Treatment Market
- Combination Anti-Diabetes Drugs Market
- Complex Regional Pain Syndrome (CRPS) Market
- Conjunctivitis Treatment Market
- Contraceptive Pills Market
- Coronary Artery Disease Therapeutics Market
- Diabetes Care Drugs Market
- Differentiated Thyroid Cancer Therapeutics Market
- Dysmenorrhea Treatment Market
- Ear Infection Treatment Market
- Egypt Diabetes Drugs Market
- Endocrinology Drugs Market
- Epilepsy Drugs Market
- Europe Biguanide Market
- Europe Cancer Vaccines Market
- Europe Diabetes Drugs Market
- Europe Glucagon-Like Peptide-1 (GLP-1) Agonists Market
- Europe Insulin Drugs And Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market
- Europe Insulin Drugs Market
- Europe Oral Anti-Diabetic Drug Market
- Europe Over-the-counter (OTC) Drugs Market
- Europe, MEA Substance Abuse Treatment Market
- Expectorant Drugs Market
- Fabry Disease Treatment Market
- Facial Erythema Treatment Market
- Facial Injectables Market
- Finland Pharmaceutical Market
- France Active Pharmaceutical Ingredients (API) Market
- France Diabetes Drugs Market
- Frontotemporal Disorders Treatment Market
- Gastric Cancer Therapy Market
- Generic Drugs Market
- Germany Diabetes Drugs Market
- Germany OTC Drug Market
- Global Angina Pectoris Drugs Market
- Global Anti-hypertensive Drugs Market
- Global Anticoagulants Market
- Global Antiemetic Drugs Market
- Global Antiparasitic Drugs Market
- Global Anxiety Disorders and Depression Treatment Market
- Global Artemisinin Combination Therapy Market
- Global Bronchitis Treatment Market
- Global Bronchodilators Market
- Global Cancer Supportive Care Drugs Market
- Global Caspofungin Market
- Global Cholera Vaccines Market
- Global Colorectal Cancer Therapeutics Market
- Global Constipation Treatment Market
- Global Corticosteroids Market
- Global Encephalitis Vaccines Market
- Global Ethical Pharmaceuticals Market
- Global Fibrate Drugs Market
- Global Geriatric Medicines Market
- Global Hematologic Malignancies Treatment Market
- Global Hereditary Angioedema Therapeutics Market
- Global Hyperlipidemia Drugs Market
- Global Hypertrophic Cardiomyopathy Therapeutics Market
- Global Immunosuppressant Drugs Market
- Global Infectious Disease Drugs Market
- Global Joint Pain Injections Market
- Global Leukemia Therapeutics Market
- Global Low Molecular Weight Heparin Market
- Global Metastatic Melanoma Drugs Market
- Global Nasopharyngeal Cancer Market
- Global Orphan Drugs Market
- Global Pediatric Drugs Market
- Global Pediatric Vaccines Market
- Global Polycystic Ovarian Syndrome Treatment Market
- Global Premenstrual Syndrome Treatment Market
- Global Pulmonary Drugs Market
- Global Rabies Vaccine Market
- Global Sinusitis Treatment Market
- Global Specialty Pharmaceuticals Market
- Global Spinal Muscular Atrophy Treatment Market
- Global Stroke Therapeutics Market
- Global Urothelial Cancer Drugs Market
- Global Varicella Vaccine Market
- Global Viscosupplementation Market
- Global Xerostomia (Dry Mouth Disease) Therapeutics Market
- Glucagon-like Peptide-1 (GLP-1) Agonists Market
- Gram-positive Bacterial Infections Market
- H1N1 Vaccines Market
- Head and Neck Cancer Therapeutics Market
- Hemoglobinopathies Treatment Market
- Hemophilia Market
- High Potency APIs /HPAPI Market
- Hospital Infection Therapeutics Market
- Human Insulin Drugs Market
- Hydroxychloroquine Drugs Market
- Hyperkalemia Treatment Market
- Iceland Pharmaceutical Market
- Immune Checkpoint Inhibitors Market
- Incretin-based Drugs Market
- India Active Pharmaceutical Ingredients (API) Market
- India Diabetes Care Drugs Market
- India Oral Anti-Diabetic Drug Market
- Indonesia Diabetes Care Drugs Market
- Influenza Medications Market
- Influenza Vaccine Market
- Injectable Anti-diabetic Drugs Market
- Injectable Drugs Market
- Insomnia Treatment Market
- Insulin Glargine Market
- Intravenous Iron Drugs Market
- Iran Diabetes Care Drugs Market
- Iron Deficiency Anemia Therapy Market
- Italy Diabetes Drugs Market
- Italy Oral Anti-Diabetic Drug Market
- Italy OTC Drugs Market
- Japan Diabetes Drugs Market
- Japan Oral Anti-Diabetic Drug Market
- Japan Pharmaceutical Market
- Korea Pharmaceutical Market
- Latin America Biguanide Market
- Latin America Bladder Cancer Therapeutics & Diagnostics Market
- Latin America Diabetes Care Drugs Market
- Latin America Glucagon-like Peptide-1 (GLP-1) Agonists Market
- Latin America Human Insulin Drugs Market
- Latin America Oral Anti-Diabetic Drug Market
- Liver Cancer Therapeutics Market
- Liver Diseases Therapeutics Market
- Lysosomal Storage Disease Treatment Market
- Malaysia Diabetes Care Drugs Market
- Malaysia Oral Anti-Diabetic Drug Market
- MEA Cancer Vaccines Market
- Meningococcal Vaccines Market
- Meperidine Drugs Market
- Mexico Diabetes Drugs Market
- Mexico Oral Anti-Diabetic Drug Market
- Middle East and Africa Biguanide Market
- Middle East and Africa Diabetes Drugs Market
- Middle East And Africa Glucagon-like Peptide-1 (GLP-1) Agonists Market
- Middle East And Africa Human Insulin Market
- Montelukast Sodium Market
- Morphine Market
- Multiple Myeloma Market
- Multiple Sclerosis Therapeutics Market
- Nasal Polyps Treatment Market
- Neurodegenerative Disease Market
- Neurological Disorder Drugs Market
- New Zealand Diabetes Drugs Market
- New Zealand Oral Anti-Diabetic Drug Market
- Non-Small Cell Lung Cancer (NSCLC) Market
- Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market
- North America Biguanide Market
- North America Cancer Vaccines Market
- North America Diabetes Drugs Market
- North America Glucagon-like Peptide-1 Agonists Market
- North America Human Insulin Drugs Market
- North America Oral Anti-Diabetic Drug Market
- North America Over the Counter Drugs Market
- North America Sulfonylureas Market
- Norway Pharmaceutical Market
- Oman Diabetes Drugs Market
- Omeprazole and Antihistamine Market
- Oral Anti-Diabetic Drugs Market
- Oral Cancer Therapy Market
- Organ Transplant Immunosuppressant Drugs Market
- Orthobiologics Market
- Osteoarthritis Treatment Market
- Over The Counter Drugs Market
- Over-the-counter (OTC) Analgesics Market
- PAP and Paracetamol Market
- Paracetamol Market
- Pelvic Inflammatory Disease Therapeutics Market
- Peptide and Anticoagulant Drugs Market
- Pharmaceutical Intermediates Market
- Philippines Diabetes Care Drugs Market
- Plantar Fasciitis Treatment Market
- Pneumococcal Vaccines Market
- Pompe Disease Market
- Proton Pump Inhibitors Market
- Pruritus Therapeutics Market
- Pseudomonas Aeruginosa Infection Treatment Market
- Psoriatic Arthritis Therapeutics Market
- Rare Disease Treatment Market
- Russia Diabetes Drugs Market
- Sarcopenia Treatment Market
- Saudi Arabia Active Pharmaceutical Ingredients (API) Market
- Saudi Arabia Diabetes Drugs Market
- Seasonal Affective Disorder Therapeutics Market
- Sickle Cell Treatment Market
- Sleep Disorders Treatment Market
- South Africa Diabetes Drugs Market
- South Korea Diabetes Drugs Market
- Spain Diabetes Care Drugs Market
- Spain Over-the-counter (OTC) Drugs Market
- Sulfonylureas Market
- Systemic Lupus Erythematosus Market
- Tetanus Toxoid Vaccine Market
- Thailand Diabetes Care Drugs Market
- Thrombosis Drugs Market
- Thyroid Cancer Therapeutics Market
- TNF Inhibitors Market
- Topical Analgesic Market
- Traveler's Diarrhea Treatment Market
- United Kingdom (UK) Diabetes Drugs Market
- United Kingdom Active Pharmaceutical Ingredients (API) Market
- United Kingdom OTC Drugs Market
- United States Active Pharmaceutical Ingredients (API) Market
- United States Heparin Market
- Uropathy Treatment Market
- US Diabetes Care Drugs Market
- Vietnam Diabetes Care Drugs Market
- Von Willebrand Disease Treatment Market
Industries Sanofi Operates Within:
Sanofi Competitors
- Abbott Laboratories
- Abbvie
- Astellas Pharma
- AstraZeneca
- Bayer
- Beckton Dickinson
- Biocon
- Boehringer Ingelheim
- Bristol-Myers Squibb
- CSL Behring
- Eli Lilly and Company
- GlaxoSmithKline
- ³Ò±ô±ð²Ô³¾²¹°ù°ìÌý±Ê³ó²¹°ù³¾²¹³¦±ð³Ü³Ù¾±³¦²¹±ô²õ
- Janssen
- ´³´Ç³ó²Ô²õ´Ç²ÔÌý&Ìý´³´Ç³ó²Ô²õ´Ç²Ô
- Medtronic
- Merck
- Novartis
- Novo Nordisk
- Pfizer
- Roche
- Sun Pharmaceuticals Industries
- Takeda Pharmaceuticals
- Teva Pharmaceutical Industries
- Ypsomed
